Asset Allocation

As of October 31, 2025.
Type % Net
Cash 0.51%
Stock 79.41%
Bond 11.49%
Convertible 0.00%
Preferred 7.25%
Other 1.34%
View Asset Allocation
Start Trial

Market Capitalization

As of October 31, 2025
Large 95.48%
Mid 3.62%
Small 0.91%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 99.84%    % Emerging Markets: 0.07%    % Unidentified Markets: 0.09%

Americas 97.12%
95.25%
Canada 80.16%
United States 15.09%
1.86%
Mexico 0.00%
As of October 31, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 2.71%
United Kingdom 0.84%
1.87%
France 0.05%
Germany 0.79%
Ireland 0.97%
Netherlands 0.00%
Spain 0.04%
Switzerland 0.00%
0.00%
0.00%
Greater Asia 0.08%
Japan 0.00%
0.08%
Australia 0.08%
0.00%
Singapore 0.00%
0.00%
Unidentified Region 0.09%

Bond Credit Quality Exposure

AAA 28.65%
AA 11.03%
A 16.32%
BBB 20.20%
BB 6.01%
B 1.77%
Below B 0.05%
    CCC 0.05%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.57%
Not Available 15.41%
Short Term 0.00%
As of October 31, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
59.65%
Materials
1.47%
Consumer Discretionary
5.25%
Financials
52.93%
Real Estate
0.00%
Sensitive
31.34%
Communication Services
1.24%
Energy
10.01%
Industrials
15.34%
Information Technology
4.76%
Defensive
8.60%
Consumer Staples
2.87%
Health Care
2.34%
Utilities
3.39%
Not Classified
0.40%
Non Classified Equity
0.27%
Not Classified - Non Equity
0.13%
As of October 31, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of October 31, 2025
Type % Net
Government 30.26%
Corporate 43.79%
Securitized 0.57%
Municipal 13.86%
Other 11.53%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
0.57%
Less than 1 Year
0.57%
Intermediate
65.13%
1 to 3 Years
5.58%
3 to 5 Years
12.35%
5 to 10 Years
47.20%
Long Term
32.86%
10 to 20 Years
7.63%
20 to 30 Years
13.55%
Over 30 Years
11.67%
Other
1.45%
As of October 31, 2025
View Bond Maturity Exposure
Start Trial